Stock Code: 300289
Stock Abbreviation: Leadman
Listing Location: Shenzhen Stock Exchange
Leadman
Beijing Leadman Biochemistry Co., Ltd.
Major Asset Purchase Report (Draft)
(Revised) Summary
Project
Major Asset Purchase
Counterparty
Hainan Baimai Investment Co., Ltd. (formerly Shanghai Baijiahui Investment Management Co., Ltd.), Hainan Sien Bio Baijiahui Technology Development Co., Ltd., Nanjing Baijiarui Enterprise Management Consulting Partnership (Limited Partnership)
Independent Financial Advisor
China Securities Co., Ltd.
Financial Advisor
Yuekai Securities Co., Ltd.
June 2026
Statement
The terms and abbreviations used in this section have the same meaning as in the "Definitions" section of this report.
I. Statement of the Listed Company
The Company guarantees that the content of the "Beijing Leadman Biochemistry Co., Ltd. Major Asset Purchase Report (Draft) (Revised)" and other application documents is true, accurate, and complete, and contains no false records, misleading statements, or major omissions. If the information disclosure in this restructuring results in false records, misleading statements, or major omissions, causing losses to investors, the Company shall bear individual and joint legal liability.
II. Statement of the Counterparties
The counterparties to this restructuring have issued the following commitments regarding the truthfulness, accuracy, and completeness of the information provided in this transaction:
-
The Company/Enterprise guarantees that the information and data provided for this transaction are true, accurate, and complete, and that there are no false records, misleading statements, or major omissions. It shall bear individual and joint legal liability for the truthfulness, accuracy, and completeness of the information provided.
-
The Company/Enterprise guarantees that it will submit all required documents and relevant information to the listed company and the intermediary institutions providing professional services for this transaction. It also undertakes that the submitted paper and electronic documents and relevant information are complete, true, and reliable, that all copies are consistent with the originals, and that all signatures and seals on the documents are authentic and valid, and have undergone the necessary legal procedures and obtained legal authorization. There are no false records, misleading statements, or major omissions.
-
The Company/Enterprise guarantees that during this transaction, it will provide information related to this transaction in a timely manner in accordance with applicable laws and regulations, and the relevant regulations of the China Securities Regulatory Commission and the Shenzhen Stock Exchange. It guarantees the truthfulness, accuracy, and completeness of such information and that there are no false records, misleading statements, or major omissions.
-
If the Company/Enterprise violates the above statements and commitments, it is willing to bear the corresponding legal liability and will be liable for compensation for any losses caused to the listed company or investors.
III. Statements of Relevant Securities Service Institutions and Personnel
(I) Statement of Independent Financial Advisor
The independent financial advisor, China Securities, which issued the independent financial advisor report for this restructuring, has issued a statement: The Company and the project personnel agree to the inclusion of relevant content from the independent financial advisor report issued by the Company in this report and its summary. The Company and the project personnel have reviewed the relevant content of the independent financial advisor report cited in this report and its summary and confirm that the cited content does not cause false records, misleading statements, or major omissions, and they shall bear the corresponding legal liability for its truthfulness, accuracy, and completeness.
(II) Statement of Financial Advisor